We’ve just launched a new portal to help you explore stocks, crypto, ETFs, and more data

BBIO

32.84000 USD
0.87
2.58%
Last update May 21, 3:59 PM EDT
Market closed
Day range
32.51000
33.68000
Previous close
33.71000
Open
33.36000
Access this stock data via API
Subscribe
BridgeBio Pharma Inc.
32.84
0.87
2.58%

Financials

Income statement

Fiscal date Mar 2025 Dec 2024 Sep 2024 Jun 2024
Total reported revenue 116.6M 5.9M 2.7M 2.2M
Cost of revenue 2.6M 2.1M 598K 598K
Gross profit 114.0M 3.8M 2.1M 1.6M
Operating expense
Research & development 111.4M 130.4M 120.4M 114.7M
Selling general and admin 106.4M 94.8M 68.8M 59.5M
Other operating expenses
Operating income -103.8M -221.3M -187.1M -172.6M
Non operating interest income
Income 5.4M 4.7M 3.3M 5.2M
Expense 42.1M 29.8M 23.1M 22.9M
Other income expense -29.1M -19.8M 42.6M 114.8M
Pretax income -169.6M -266.2M -164.3M -75.5M
Tax provision
Net income -169.6M -267.4M -164.3M -75.5M
Basic EPS -1.4 -0.9 -0.4
Diluted EPS -1.4 -0.9 -0.4
Basic average shares 189.4M 188.5M 187.6M
Diluted average shares 189.4M 188.5M 187.6M
EBITDA -104.5M -227.8M -188.9M -173.3M
Net income from continuing op. -169.6M -267.4M -164.3M -75.5M
Minority interests 2.2M 2.3M 2.2M 2.1M
Preferred stock dividends
Market closed

Exchange is currently closed
Pre-market opens in 44 minutes

03:15
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).